Cargando…
International Nosocomial Infection Control Consortium (INICC) national report on device-associated infection rates in 19 cities of Turkey, data summary for 2003–2012
BACKGROUND: Device-associated healthcare-acquired infections (DA-HAI) pose a threat to patient safety, particularly in the intensive care unit (ICU). We report the results of the International Infection Control Consortium (INICC) study conducted in Turkey from August 2003 through October 2012. METHO...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4255447/ https://www.ncbi.nlm.nih.gov/pubmed/25403704 http://dx.doi.org/10.1186/s12941-014-0051-3 |
_version_ | 1782347433991208960 |
---|---|
author | Leblebicioglu, Hakan Erben, Nurettin Rosenthal, Victor Daniel Atasay, Begüm Erbay, Ayse Unal, Serhat Senol, Gunes Willke, Ayse Özgültekin, Asu Altin, Nilgün Bakir, Mehmet Oncul, Oral Ersöz, Gülden Ozdemir, Davut Yalcin, Ata Nevzat Özdemir, Halil Yıldızdaş, Dinçer Koksal, Iftihar Aygun, Canan Sirmatel, Fatma Sener, Alper Tuna, Nazan Akan, Özay Arikan Turgut, Huseyin Demiroz, A Pekcan Kendirli, Tanil Alp, Emine Uzun, Cengiz Ulusoy, Sercan Arman, Dilek |
author_facet | Leblebicioglu, Hakan Erben, Nurettin Rosenthal, Victor Daniel Atasay, Begüm Erbay, Ayse Unal, Serhat Senol, Gunes Willke, Ayse Özgültekin, Asu Altin, Nilgün Bakir, Mehmet Oncul, Oral Ersöz, Gülden Ozdemir, Davut Yalcin, Ata Nevzat Özdemir, Halil Yıldızdaş, Dinçer Koksal, Iftihar Aygun, Canan Sirmatel, Fatma Sener, Alper Tuna, Nazan Akan, Özay Arikan Turgut, Huseyin Demiroz, A Pekcan Kendirli, Tanil Alp, Emine Uzun, Cengiz Ulusoy, Sercan Arman, Dilek |
author_sort | Leblebicioglu, Hakan |
collection | PubMed |
description | BACKGROUND: Device-associated healthcare-acquired infections (DA-HAI) pose a threat to patient safety, particularly in the intensive care unit (ICU). We report the results of the International Infection Control Consortium (INICC) study conducted in Turkey from August 2003 through October 2012. METHODS: A DA-HAI surveillance study in 63 adult, paediatric ICUs and neonatal ICUs (NICUs) from 29 hospitals, in 19 cities using the methods and definitions of the U.S. NHSN and INICC methods. RESULTS: We collected prospective data from 94,498 ICU patients for 647,316 bed days. Pooled DA-HAI rates for adult and paediatric ICUs were 11.1 central line-associated bloodstream infections (CLABSIs) per 1000 central line (CL)-days, 21.4 ventilator-associated pneumonias (VAPs) per 1000 mechanical ventilator (MV)-days and 7.5 catheter-associated urinary tract infections (CAUTIs) per 1000 urinary catheter-days. Pooled DA-HAI rates for NICUs were 30 CLABSIs per 1000 CL-days, and 15.8 VAPs per 1000 MV-days. Extra length of stay (LOS) in adult and paediatric ICUs was 19.4 for CLABSI, 8.7 for VAP and 10.1 for CAUTI. Extra LOS in NICUs was 13.1 for patients with CLABSI and 16.2 for patients with VAP. Extra crude mortality was 12% for CLABSI, 19.4% for VAP and 10.5% for CAUTI in ICUs, and 15.4% for CLABSI and 10.5% for VAP in NICUs. Pooled device use (DU) ratios for adult and paediatric ICUs were 0.54 for MV, 0.65 for CL and 0.88 for UC, and 0.12 for MV, and 0.09 for CL in NICUs. The CLABSI rate was 8.5 per 1,000 CL days in the Medical Surgical ICUs included in this study, which is higher than the INICC report rate of 4.9, and more than eight times higher than the NHSN rate of 0.9. Similarly, the VAP and CAUTI rates were higher compared with U.S. NHSN (22.3 vs. 1.1 for VAP; 7.9 vs. 1.2 for CAUTI) and with the INICC report (22.3 vs. 16.5 in VAP; 7.9 vs. 5.3 in CAUTI). CONCLUSIONS: DA-HAI rates and DU ratios in our ICUs were higher than those reported in the INICC global report and in the US NHSN report. |
format | Online Article Text |
id | pubmed-4255447 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-42554472014-12-05 International Nosocomial Infection Control Consortium (INICC) national report on device-associated infection rates in 19 cities of Turkey, data summary for 2003–2012 Leblebicioglu, Hakan Erben, Nurettin Rosenthal, Victor Daniel Atasay, Begüm Erbay, Ayse Unal, Serhat Senol, Gunes Willke, Ayse Özgültekin, Asu Altin, Nilgün Bakir, Mehmet Oncul, Oral Ersöz, Gülden Ozdemir, Davut Yalcin, Ata Nevzat Özdemir, Halil Yıldızdaş, Dinçer Koksal, Iftihar Aygun, Canan Sirmatel, Fatma Sener, Alper Tuna, Nazan Akan, Özay Arikan Turgut, Huseyin Demiroz, A Pekcan Kendirli, Tanil Alp, Emine Uzun, Cengiz Ulusoy, Sercan Arman, Dilek Ann Clin Microbiol Antimicrob Research BACKGROUND: Device-associated healthcare-acquired infections (DA-HAI) pose a threat to patient safety, particularly in the intensive care unit (ICU). We report the results of the International Infection Control Consortium (INICC) study conducted in Turkey from August 2003 through October 2012. METHODS: A DA-HAI surveillance study in 63 adult, paediatric ICUs and neonatal ICUs (NICUs) from 29 hospitals, in 19 cities using the methods and definitions of the U.S. NHSN and INICC methods. RESULTS: We collected prospective data from 94,498 ICU patients for 647,316 bed days. Pooled DA-HAI rates for adult and paediatric ICUs were 11.1 central line-associated bloodstream infections (CLABSIs) per 1000 central line (CL)-days, 21.4 ventilator-associated pneumonias (VAPs) per 1000 mechanical ventilator (MV)-days and 7.5 catheter-associated urinary tract infections (CAUTIs) per 1000 urinary catheter-days. Pooled DA-HAI rates for NICUs were 30 CLABSIs per 1000 CL-days, and 15.8 VAPs per 1000 MV-days. Extra length of stay (LOS) in adult and paediatric ICUs was 19.4 for CLABSI, 8.7 for VAP and 10.1 for CAUTI. Extra LOS in NICUs was 13.1 for patients with CLABSI and 16.2 for patients with VAP. Extra crude mortality was 12% for CLABSI, 19.4% for VAP and 10.5% for CAUTI in ICUs, and 15.4% for CLABSI and 10.5% for VAP in NICUs. Pooled device use (DU) ratios for adult and paediatric ICUs were 0.54 for MV, 0.65 for CL and 0.88 for UC, and 0.12 for MV, and 0.09 for CL in NICUs. The CLABSI rate was 8.5 per 1,000 CL days in the Medical Surgical ICUs included in this study, which is higher than the INICC report rate of 4.9, and more than eight times higher than the NHSN rate of 0.9. Similarly, the VAP and CAUTI rates were higher compared with U.S. NHSN (22.3 vs. 1.1 for VAP; 7.9 vs. 1.2 for CAUTI) and with the INICC report (22.3 vs. 16.5 in VAP; 7.9 vs. 5.3 in CAUTI). CONCLUSIONS: DA-HAI rates and DU ratios in our ICUs were higher than those reported in the INICC global report and in the US NHSN report. BioMed Central 2014-11-18 /pmc/articles/PMC4255447/ /pubmed/25403704 http://dx.doi.org/10.1186/s12941-014-0051-3 Text en © Leblebicioglu et al.; licensee BioMed Central Ltd. 2014 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Leblebicioglu, Hakan Erben, Nurettin Rosenthal, Victor Daniel Atasay, Begüm Erbay, Ayse Unal, Serhat Senol, Gunes Willke, Ayse Özgültekin, Asu Altin, Nilgün Bakir, Mehmet Oncul, Oral Ersöz, Gülden Ozdemir, Davut Yalcin, Ata Nevzat Özdemir, Halil Yıldızdaş, Dinçer Koksal, Iftihar Aygun, Canan Sirmatel, Fatma Sener, Alper Tuna, Nazan Akan, Özay Arikan Turgut, Huseyin Demiroz, A Pekcan Kendirli, Tanil Alp, Emine Uzun, Cengiz Ulusoy, Sercan Arman, Dilek International Nosocomial Infection Control Consortium (INICC) national report on device-associated infection rates in 19 cities of Turkey, data summary for 2003–2012 |
title | International Nosocomial Infection Control Consortium (INICC) national report on device-associated infection rates in 19 cities of Turkey, data summary for 2003–2012 |
title_full | International Nosocomial Infection Control Consortium (INICC) national report on device-associated infection rates in 19 cities of Turkey, data summary for 2003–2012 |
title_fullStr | International Nosocomial Infection Control Consortium (INICC) national report on device-associated infection rates in 19 cities of Turkey, data summary for 2003–2012 |
title_full_unstemmed | International Nosocomial Infection Control Consortium (INICC) national report on device-associated infection rates in 19 cities of Turkey, data summary for 2003–2012 |
title_short | International Nosocomial Infection Control Consortium (INICC) national report on device-associated infection rates in 19 cities of Turkey, data summary for 2003–2012 |
title_sort | international nosocomial infection control consortium (inicc) national report on device-associated infection rates in 19 cities of turkey, data summary for 2003–2012 |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4255447/ https://www.ncbi.nlm.nih.gov/pubmed/25403704 http://dx.doi.org/10.1186/s12941-014-0051-3 |
work_keys_str_mv | AT leblebiciogluhakan internationalnosocomialinfectioncontrolconsortiuminiccnationalreportondeviceassociatedinfectionratesin19citiesofturkeydatasummaryfor20032012 AT erbennurettin internationalnosocomialinfectioncontrolconsortiuminiccnationalreportondeviceassociatedinfectionratesin19citiesofturkeydatasummaryfor20032012 AT rosenthalvictordaniel internationalnosocomialinfectioncontrolconsortiuminiccnationalreportondeviceassociatedinfectionratesin19citiesofturkeydatasummaryfor20032012 AT atasaybegum internationalnosocomialinfectioncontrolconsortiuminiccnationalreportondeviceassociatedinfectionratesin19citiesofturkeydatasummaryfor20032012 AT erbayayse internationalnosocomialinfectioncontrolconsortiuminiccnationalreportondeviceassociatedinfectionratesin19citiesofturkeydatasummaryfor20032012 AT unalserhat internationalnosocomialinfectioncontrolconsortiuminiccnationalreportondeviceassociatedinfectionratesin19citiesofturkeydatasummaryfor20032012 AT senolgunes internationalnosocomialinfectioncontrolconsortiuminiccnationalreportondeviceassociatedinfectionratesin19citiesofturkeydatasummaryfor20032012 AT willkeayse internationalnosocomialinfectioncontrolconsortiuminiccnationalreportondeviceassociatedinfectionratesin19citiesofturkeydatasummaryfor20032012 AT ozgultekinasu internationalnosocomialinfectioncontrolconsortiuminiccnationalreportondeviceassociatedinfectionratesin19citiesofturkeydatasummaryfor20032012 AT altinnilgun internationalnosocomialinfectioncontrolconsortiuminiccnationalreportondeviceassociatedinfectionratesin19citiesofturkeydatasummaryfor20032012 AT bakirmehmet internationalnosocomialinfectioncontrolconsortiuminiccnationalreportondeviceassociatedinfectionratesin19citiesofturkeydatasummaryfor20032012 AT onculoral internationalnosocomialinfectioncontrolconsortiuminiccnationalreportondeviceassociatedinfectionratesin19citiesofturkeydatasummaryfor20032012 AT ersozgulden internationalnosocomialinfectioncontrolconsortiuminiccnationalreportondeviceassociatedinfectionratesin19citiesofturkeydatasummaryfor20032012 AT ozdemirdavut internationalnosocomialinfectioncontrolconsortiuminiccnationalreportondeviceassociatedinfectionratesin19citiesofturkeydatasummaryfor20032012 AT yalcinatanevzat internationalnosocomialinfectioncontrolconsortiuminiccnationalreportondeviceassociatedinfectionratesin19citiesofturkeydatasummaryfor20032012 AT ozdemirhalil internationalnosocomialinfectioncontrolconsortiuminiccnationalreportondeviceassociatedinfectionratesin19citiesofturkeydatasummaryfor20032012 AT yıldızdasdincer internationalnosocomialinfectioncontrolconsortiuminiccnationalreportondeviceassociatedinfectionratesin19citiesofturkeydatasummaryfor20032012 AT koksaliftihar internationalnosocomialinfectioncontrolconsortiuminiccnationalreportondeviceassociatedinfectionratesin19citiesofturkeydatasummaryfor20032012 AT ayguncanan internationalnosocomialinfectioncontrolconsortiuminiccnationalreportondeviceassociatedinfectionratesin19citiesofturkeydatasummaryfor20032012 AT sirmatelfatma internationalnosocomialinfectioncontrolconsortiuminiccnationalreportondeviceassociatedinfectionratesin19citiesofturkeydatasummaryfor20032012 AT seneralper internationalnosocomialinfectioncontrolconsortiuminiccnationalreportondeviceassociatedinfectionratesin19citiesofturkeydatasummaryfor20032012 AT tunanazan internationalnosocomialinfectioncontrolconsortiuminiccnationalreportondeviceassociatedinfectionratesin19citiesofturkeydatasummaryfor20032012 AT akanozayarikan internationalnosocomialinfectioncontrolconsortiuminiccnationalreportondeviceassociatedinfectionratesin19citiesofturkeydatasummaryfor20032012 AT turguthuseyin internationalnosocomialinfectioncontrolconsortiuminiccnationalreportondeviceassociatedinfectionratesin19citiesofturkeydatasummaryfor20032012 AT demirozapekcan internationalnosocomialinfectioncontrolconsortiuminiccnationalreportondeviceassociatedinfectionratesin19citiesofturkeydatasummaryfor20032012 AT kendirlitanil internationalnosocomialinfectioncontrolconsortiuminiccnationalreportondeviceassociatedinfectionratesin19citiesofturkeydatasummaryfor20032012 AT alpemine internationalnosocomialinfectioncontrolconsortiuminiccnationalreportondeviceassociatedinfectionratesin19citiesofturkeydatasummaryfor20032012 AT uzuncengiz internationalnosocomialinfectioncontrolconsortiuminiccnationalreportondeviceassociatedinfectionratesin19citiesofturkeydatasummaryfor20032012 AT ulusoysercan internationalnosocomialinfectioncontrolconsortiuminiccnationalreportondeviceassociatedinfectionratesin19citiesofturkeydatasummaryfor20032012 AT armandilek internationalnosocomialinfectioncontrolconsortiuminiccnationalreportondeviceassociatedinfectionratesin19citiesofturkeydatasummaryfor20032012 |